Literature DB >> 26902726

Pseudomonas aeruginosa and Its Bacterial Components Influence the Cytokine Response in Thymocytes and Splenocytes.

Andreas Weber1, Corinna Zimmermann2, Anne K Mausberg2, Thomas Dehmel2, Bernd C Kieseier2, Hans-Peter Hartung2, Harald H Hofstetter2.   

Abstract

Infections with Pseudomonas aeruginosa may cause many different diseases. The spectrum of such infections in general includes inflammation and bacterial sepsis. Hospital-acquired pneumonia, naturally resistant to a wide range of antibiotics, is associated with a particularly high mortality rate in mechanically ventilated patients. The pathogenesis of P. aeruginosa is complex and mediated by several virulence factors, as well as cell-associated factors. We have previously demonstrated that stimulation with different bacteria triggers the cytokine response of thymocytes. In this study, we investigated the effect of P. aeruginosa and its different components on the cytokine production of immature and mature immune cells. We found that the induced cytokine pattern in the thymus and the spleen after infections with P. aeruginosa is primarily mediated by lipopolysaccharide (LPS) of the outer cell membrane, but other components of the bacterium can influence the cytokine secretion as well. Stimulation with heat-killed P. aeruginosa and LPS does not influence the amount of cytokine-producing CD4(+) T cells but instead suppresses the emergence of Th17 cells. However, stimulation with P. aeruginosa or its components triggers the interleukin-17 (IL-17) response both in thymocytes and in splenocytes. We conclude that infections with P. aeruginosa affect the cytokine secretion of immature and mature cells and that IL-17 and Th17 cells play only a minor role in the development of pathological systemic inflammatory disease conditions during P. aeruginosa infections. Therefore, other inflammatory immune responses must be responsible for septic reactions of the host.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26902726      PMCID: PMC4862705          DOI: 10.1128/IAI.00905-15

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  53 in total

Review 1.  Sepsis: the inflammatory foundation of pathophysiology and therapy.

Authors:  Joan Li; Brendan Carr; Munish Goyal; David F Gaieski
Journal:  Hosp Pract (1995)       Date:  2011-08

Review 2.  Pseudomonas aeruginosa: new insights into pathogenesis and host defenses.

Authors:  Shaan L Gellatly; Robert E W Hancock
Journal:  Pathog Dis       Date:  2013-03-15       Impact factor: 3.166

Review 3.  Pneumonia due to Pseudomonas aeruginosa: part I: epidemiology, clinical diagnosis, and source.

Authors:  Shigeki Fujitani; Hsin-Yun Sun; Victor L Yu; Jeremy A Weingarten
Journal:  Chest       Date:  2011-04       Impact factor: 9.410

Review 4.  Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases.

Authors:  Jane Hoyt Buckner
Journal:  Nat Rev Immunol       Date:  2010-12       Impact factor: 53.106

Review 5.  Innate IL-17-producing cells: the sentinels of the immune system.

Authors:  Daniel J Cua; Cristina M Tato
Journal:  Nat Rev Immunol       Date:  2010-06-18       Impact factor: 53.106

Review 6.  Hospital-acquired pneumonia: pathophysiology, diagnosis, and treatment.

Authors:  Alicia N Kieninger; Pamela A Lipsett
Journal:  Surg Clin North Am       Date:  2009-04       Impact factor: 2.741

Review 7.  Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.

Authors:  Philip D Lister; Daniel J Wolter; Nancy D Hanson
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

Review 8.  Regulatory molecules required for nucleotide-sensing Toll-like receptors.

Authors:  Shin-Ichiroh Saitoh; Kensuke Miyake
Journal:  Immunol Rev       Date:  2009-01       Impact factor: 12.988

Review 9.  Toll-like receptors.

Authors:  Kiyoshi Takeda; Tsuneyasu Kaisho; Shizuo Akira
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

Review 10.  Pseudomonas exotoxin A: from virulence factor to anti-cancer agent.

Authors:  Philipp Wolf; Ursula Elsässer-Beile
Journal:  Int J Med Microbiol       Date:  2008-10-23       Impact factor: 3.658

View more
  5 in total

1.  Regulatory T cell activity in immunosuppresive mice model of pseudomonas aeruginosa pneumonia.

Authors:  Jun-Lu Li; Ting-Sang Chen; Cong-Cong Yuan; Guo-Qiang Zhao; Min Xu; Xiao-Yan Li; Jie Cao; Li-Hua Xing
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-08-08

2.  Gut Microbiota Protected Against pseudomonas aeruginosa Pneumonia via Restoring Treg/Th17 Balance and Metabolism.

Authors:  Long Wen; Lei Shi; Xiang-Long Kong; Ke-Yu Li; Hui Li; Di-Xuan Jiang; Fan Zhang; Zhi-Guo Zhou
Journal:  Front Cell Infect Microbiol       Date:  2022-06-16       Impact factor: 6.073

3.  Virulence and resistance determinants in Pseudomonas aeruginosa isolated from pericarditis in diseased broiler chickens in Egypt.

Authors:  Walid Hamdy Hassan; Ahmed Mohamed Kamel Ibrahim; Salama Abohamra Sayed Shany; Hala Sayed Hassan Salam
Journal:  J Adv Vet Anim Res       Date:  2020-08-05

4.  Exotoxin A-PLGA nanoconjugate vaccine against Pseudomonas aeruginosa infection: protectivity in murine model.

Authors:  Leila Safari Zanjani; Reza Shapouri; Mehrouz Dezfulian; Mehdi Mahdavi; Mehdi Shafiee Ardestani
Journal:  World J Microbiol Biotechnol       Date:  2019-06-11       Impact factor: 4.253

5.  Low-Dose Methotrexate Prevents Primary and Secondary Humoral Immune Responses and Induces Immune Tolerance to a Recombinant Immunotoxin.

Authors:  Emily M King; Ronit Mazor; Nicolas Çuburu; Ira Pastan
Journal:  J Immunol       Date:  2018-02-05       Impact factor: 5.426

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.